Thermo Fisher Scientific Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 36.5B 42.9B 44.9B 39.2B
Cost of revenue 21.4B 25.8B 25.9B 19.6B
Gross profit 15.1B 17.1B 19.0B 19.6B
Operating expense
Research & development 1.2B 1.3B 1.5B 1.4B
Selling general and admin 7.3B 8.4B 9.0B 8.0B
Other operating expenses
Operating income 6.6B 7.3B 8.5B 10.2B
Non operating interest income
Income 918.2M 879M 272M 43M
Expense 1.2B 1.4B 726M 536M
Other income expense -312.6M -524M -218M -891M
Pretax income 6.0B 6.3B 7.8B 8.8B
Tax provision 559.6M 284M 703M 1.1B
Net income 5.4B 6.0B 7.0B 7.7B
Basic EPS 16.6 15.5 17.8 19.6
Diluted EPS 16.5 15.5 17.6 19.5
Basic average shares 325.4M 401.7M 408.0M 410.0M
Diluted average shares 325.4M 401.7M 408.0M 410.0M
EBITDA 10.1B 11.6B 12.2B 12.2B
Net income from continuing op. 5.4B 6.0B 7.0B 7.7B
Minority interests -3M 40M -10M -3M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 38 minutes

09:56
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).